rs140731963

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 3P and 16B. PM1PP2BP4_StrongBP6_Very_StrongBS2

The NM_001165963.4(SCN1A):​c.3749C>T​(p.Thr1250Met) variant causes a missense change. The variant allele was found at a frequency of 0.000246 in 1,609,596 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 1 hom. )

Consequence

SCN1A
NM_001165963.4 missense

Scores

5
10
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.01
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

PM1
In a topological_domain Extracellular (size 12) in uniprot entity SCN1A_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_001165963.4
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SCN1A. . Gene score misZ 5.2206 (greater than the threshold 3.09). Trascript score misZ 7.6022 (greater than threshold 3.09). GenCC has associacion of gene with migraine, familial hemiplegic, 3, familial hemiplegic migraine, Dravet syndrome, malignant migrating partial seizures of infancy, generalized epilepsy with febrile seizures plus, myoclonic-astatic epilepsy, developmental and epileptic encephalopathy, developmental and epileptic encephalopathy, 6, familial or sporadic hemiplegic migraine, arthrogryposis, Lennox-Gastaut syndrome, generalized epilepsy with febrile seizures plus, type 2.
BP4
Computational evidence support a benign effect (MetaRNN=0.053359985).
BP6
Variant 2-166012239-G-A is Benign according to our data. Variant chr2-166012239-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 206807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 37 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCN1ANM_001165963.4 linkuse as main transcriptc.3749C>T p.Thr1250Met missense_variant 22/29 ENST00000674923.1 NP_001159435.1
LOC102724058NR_110598.1 linkuse as main transcriptn.176-3374G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCN1AENST00000674923.1 linkuse as main transcriptc.3749C>T p.Thr1250Met missense_variant 22/29 NM_001165963.4 ENSP00000501589 P4P35498-1
SCN1A-AS1ENST00000651574.1 linkuse as main transcriptn.193-3374G>A intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.000245
AC:
37
AN:
151114
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000485
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000662
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000163
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000405
AC:
101
AN:
249310
Hom.:
0
AF XY:
0.000401
AC XY:
54
AN XY:
134820
show subpopulations
Gnomad AFR exome
AF:
0.0000619
Gnomad AMR exome
AF:
0.000175
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00302
Gnomad NFE exome
AF:
0.000196
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000246
AC:
359
AN:
1458364
Hom.:
1
Cov.:
30
AF XY:
0.000252
AC XY:
183
AN XY:
725490
show subpopulations
Gnomad4 AFR exome
AF:
0.0000900
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000209
Gnomad4 FIN exome
AF:
0.00311
Gnomad4 NFE exome
AF:
0.000135
Gnomad4 OTH exome
AF:
0.000216
GnomAD4 genome
AF:
0.000245
AC:
37
AN:
151232
Hom.:
0
Cov.:
32
AF XY:
0.000311
AC XY:
23
AN XY:
73902
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.0000661
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00198
Gnomad4 NFE
AF:
0.000163
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000176
Hom.:
0
Bravo
AF:
0.000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000363
AC:
44
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxFeb 27, 2019This variant is associated with the following publications: (PMID: 27231140, 19522081, 21719429, 28202706, 28150151, 26990884, 31009440) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2023SCN1A: PP2, BS1 -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 10, 2023Variant summary: SCN1A c.3749C>T (p.Thr1250Met) results in a non-conservative amino acid change located in the ion transport domain (IPR005821) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00041 in 249310 control chromosomes. The observed variant frequency is approximately 23-fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN1A causing SCN1A-Related Seizure Disorder phenotype (1.8e-05), strongly suggesting that the variant is benign. c.3749C>T has been reported in the literature in individuals affected with Seizure Disorders, without evidence for causality (i.e. lack of segregation or segregation data not provided) and in one case where the variant co-occurred with a pathogenic variant (c.3706-2A>G), providing supporting evidence for a benign role (e.g. Orrico_2009, Catarino_2011, Lal_2016, Fang_2019). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 21719429, 19522081, 31009440, 26990884). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as either benign (n=2)/likely benign (n=1), or VUS (=1). Based on the evidence outlined above, the variant was classified as benign. -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 17, 2022This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 08, 2021- -
SCN1A-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 10, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Severe myoclonic epilepsy in infancy Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Pathogenic
0.39
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.92
.;.;.;D;.;.;D;.;.;.
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.89
D;D;D;D;.;D;.;.;D;D
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.053
T;T;T;T;T;T;T;T;T;T
MetaSVM
Pathogenic
0.93
D
MutationAssessor
Uncertain
2.5
.;.;.;M;.;.;M;.;.;.
MutationTaster
Benign
0.98
D;D;D;D
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-2.5
.;.;.;D;.;.;D;.;D;D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.0030
.;.;.;D;.;.;D;.;D;D
Sift4G
Benign
0.10
.;.;.;T;.;.;T;.;T;T
Polyphen
0.013, 0.60
.;.;.;B;P;.;B;P;P;.
Vest4
0.50, 0.51, 0.48, 0.51
MVP
0.99
MPC
1.0
ClinPred
0.057
T
GERP RS
4.4
Varity_R
0.18
gMVP
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140731963; hg19: chr2-166868749; COSMIC: COSV57665739; COSMIC: COSV57665739; API